Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients

Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients

Abstract Background The use of alpha‐fetoprotein (AFP) testing for the surveillance, diagnosis, and prognosis of hepatocellular carcinoma (HCC) remains controversial. Here, we compared AFP testing rates, elevated AFP rates, factors associated with elevated AFP levels, and prognostic factors associat...

Full description

Bibliographic Details
Main Authors: Guoyi Wu, Jing Wu, Xiaoben Pan, Bo Liu, Zhicheng Yao, Yuan Guo, Xiaolei Shi, Yitao Ding
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Cancer Medicine
Subjects:
alpha‐fetoprotein
diagnosis
end results
epidemiology
hepatocellular carcinoma
overall survival
Online Access:https://doi.org/10.1002/cam4.2549

Internet

https://doi.org/10.1002/cam4.2549

Similar Items